Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2011 | 07-2011 | 04-2011 | 01-2011 | 10-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,799 | -2,869 | N/A | -7,598 | -5,054 |
| Depreciation Amortization | 1,414 | 91 | N/A | 255 | 191 |
| Accounts receivable | -171 | 141 | N/A | 95 | 154 |
| Other Working Capital | -304 | 213 | N/A | 473 | 322 |
| Other Operating Activity | 276 | 370 | 0 | 123 | -2 |
| Operating Cash Flow | $-4,584 | $-2,054 | $N/A | $-6,653 | $-4,390 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | N/A | N/A | -188 | -139 |
| Purchase Sale Intangibles | -153 | -87 | N/A | -183 | -119 |
| Other Investing Activity | -153 | -87 | 0 | -183 | -119 |
| Investing Cash Flow | $-162 | $-87 | $N/A | $-371 | $-257 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 4,514 | 4,514 | N/A | N/A | N/A |
| Debt Issued | 700 | 700 | N/A | 2,089 | N/A |
| Common Stock Issued | 619 | N/A | N/A | 4,901 | 4,901 |
| Other Financing Activity | -36 | -28 | 0 | -77 | -50 |
| Financing Cash Flow | $5,797 | $5,187 | $N/A | $6,913 | $4,852 |
| Beginning Cash Position | 952 | 952 | N/A | 633 | 633 |
| End Cash Position | 2,004 | 3,998 | N/A | 522 | 837 |
| Net Cash Flow | $1,052 | $3,046 | $N/A | $-110 | $205 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,584 | -2,054 | N/A | -6,653 | -4,390 |
| Capital Expenditure | -9 | N/A | N/A | -188 | -139 |
| Free Cash Flow | -4,592 | -2,054 | 0 | -6,840 | -4,529 |